TITLE:
A drospirenone-containing oral contraceptive improved bleeding pattern and personal satisfaction in 914 women from Jordan, Lebanon and Syria
AUTHORS:
Ramzi Finan, Abeer Wasfi Annab, Salwa Abdalla, Farid Bedran, Mazen El-Zibdeh, Lina Shahen, Christoph Gerlinger, Erich Solomayer, Kubilay Ertan, Jan Endrikat
KEYWORDS:
Bleeding Pattern; Tolerance; Drospirenone; Oral Contraception
JOURNAL NAME:
Health,
Vol.5 No.7D,
July
10,
2013
ABSTRACT: Aim: We assessed bleeding
pattern, tolerance and patient satisfaction of an oral contraceptive
containing 3 mg drospirenone and 30 mcg ethinyl
estradiol (DRSP/EE) under real-life conditions. Study Design: We performed a multicenter, prospective,
6-cycle, observational study in Canada, Europe and the Middle East. Detailed
analyses of the three Middle East countries, Jordan, Lebanon andSyriawere
presented here. The efficacy variables included an assessment of bleeding
patterns, premenstrual symptoms of water retention and patient satisfaction,
as determined by a visual analogue scale. Results:
A total of 914 women were enrolled. The percentage of women with intermenstrual
bleeding decreased from 37.4%,
48.7% and 32.2% at baseline to 9.7%, 6.1% and 10.9% at the end of cycle6 inJordan, Lebanon and Syria, respectively
(creased sharply in all three countries (p Amenorrhea decreased significantly in Lebanon and Syria (p